These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 2421002

  • 21. CNS myelinogenesis in vitro: time course and pattern of rat oligodendrocyte development.
    Asou H, Hamada K, Miyazaki T, Sakota T, Hayashi K, Takeda Y, Marret S, Delpech B, Itoh K, Uyemura K.
    J Neurosci Res; 1995 Mar 01; 40(4):519-34. PubMed ID: 7616612
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Electron microscopic immunocytochemical localization of myelin proteolipid protein and myelin basic protein to oligodendrocytes in rat brain during myelination.
    Schwob VS, Clark HB, Agrawal D, Agrawal HC.
    J Neurochem; 1985 Aug 01; 45(2):559-71. PubMed ID: 2409233
    [Abstract] [Full Text] [Related]

  • 29. CNS myelinogenesis in vitro: myelin basic protein deficient shiverer oligodendrocytes.
    Seiwa C, Kojima-Aikawa K, Matsumoto I, Asou H.
    J Neurosci Res; 2002 Aug 01; 69(3):305-17. PubMed ID: 12125072
    [Abstract] [Full Text] [Related]

  • 30. Toll-like receptors 2 and 3 agonists differentially affect oligodendrocyte survival, differentiation, and myelin membrane formation.
    Bsibsi M, Nomden A, van Noort JM, Baron W.
    J Neurosci Res; 2012 Feb 01; 90(2):388-98. PubMed ID: 21971760
    [Abstract] [Full Text] [Related]

  • 31. Stimulation of oligodendrocytes by extracts from astrocyte-enriched cultures.
    Bhat S, Pfeiffer SE.
    J Neurosci Res; 1986 Feb 01; 15(1):19-27. PubMed ID: 3959127
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Oligodendrocyte maturation is inhibited by bone morphogenetic protein.
    See J, Zhang X, Eraydin N, Mun SB, Mamontov P, Golden JA, Grinspan JB.
    Mol Cell Neurosci; 2004 Aug 01; 26(4):481-92. PubMed ID: 15276151
    [Abstract] [Full Text] [Related]

  • 34. Basic fibroblast growth factor down-regulates myelin basic protein gene expression and alters myelin compaction of mature oligodendrocytes in vitro.
    Fressinaud C, Vallat JM, Labourdette G.
    J Neurosci Res; 1995 Feb 15; 40(3):285-93. PubMed ID: 7745622
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Participation of galactosylceramide and sulfatide in glycosynapses between oligodendrocyte or myelin membranes.
    Boggs JM, Gao W, Zhao J, Park HJ, Liu Y, Basu A.
    FEBS Lett; 2010 May 03; 584(9):1771-8. PubMed ID: 19941861
    [Abstract] [Full Text] [Related]

  • 38. Myelin palingenesis. 2. Immunocytochemical localization of myelin/oligodendrocyte glycolipids in multilamellar structures.
    Arvanitis D, Dumas M, Szuchet S.
    Dev Neurosci; 1992 May 03; 14(5-6):328-35. PubMed ID: 1306158
    [Abstract] [Full Text] [Related]

  • 39. Identification of GTP-binding proteins in myelin and oligodendrocyte membranes.
    Braun PE, Horvath E, Yong VW, Bernier L.
    J Neurosci Res; 1990 May 03; 26(1):16-23. PubMed ID: 2113588
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.